Achieve Life Sciences, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Achieve Life Sciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $160.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $178.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-09-30 was $126.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $178.00K.
- Achieve Life Sciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $126.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $160.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $178.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $178.00K 10-Q · filed 2025-11-06 | |
| 2022-12-31 | $126.00K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $126.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |